Use of Tamoxifen With Postsurgical Irradiation May Improve Survival in Estrogen and Progesterone Receptor–Positive Male Breast Cancer
- 1 February 2011
- journal article
- Published by Elsevier BV in Clinical Breast Cancer
- Vol. 11 (1), 39-45
- https://doi.org/10.3816/cbc.2011.n.007
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Tamoxifen with or without Breast Irradiation in Women 50 Years of Age or Older with Early Breast CancerThe New England Journal of Medicine, 2004
- Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast CancerThe New England Journal of Medicine, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Is Male Breast Cancer Similar or Different than Female Breast Cancer?Breast Cancer Research and Treatment, 2004
- Tamoxifen, Radiation Therapy, or Both for Prevention of Ipsilateral Breast Tumor Recurrence After Lumpectomy in Women With Invasive Breast Cancers of One Centimeter or LessJournal of Clinical Oncology, 2002
- Male breast carcinomaCancer, 1999
- Male breast cancer: a 22-year experienceEuropean Journal of Surgical Oncology, 1998
- Male breast cancer: Results of the treatments and prognostic factors in 397 casesEuropean Journal of Cancer, 1995
- Review article: Epidemiology of male breast cancer. A meta‐analysis of published case‐control studies and discussion of selected aetiological factorsInternational Journal of Cancer, 1993